0,928  0,005  Apoptosis agonist
0,916  0,004  Antineoplastic (breast cancer)
0,877  0,002  TRPA1 agonist
0,854  0,005  Antineoplastic (lung cancer)
0,837  0,005  Antileukemic
0,838  0,006  Caspase 9 stimulant
0,819  0,005  Antineoplastic (colon cancer)
0,818  0,006  Antineoplastic (colorectal cancer)
0,779  0,005  Antineoplastic (melanoma)
0,761  0,006  Sensitization
0,756  0,022  Antiinflammatory
0,706  0,004  Antineoplastic (multiple myeloma)
0,707  0,009  Prostate cancer treatment
0,698  0,005  Antineoplastic (brain cancer)
0,693  0,004  Antineoplastic (renal cancer)
0,661  0,007  Nitric oxide antagonist
0,654  0,005  Antineoplastic (liver cancer)
0,600  0,016  Antineoplastic (ovarian cancer)
0,590  0,009  Antineoplastic (glioma)
0,565  0,008  Antineoplastic (osteosarcoma)
0,570  0,017  CYP2C19 substrate
0,560  0,008  Antineoplastic (glioblastoma multiforme)
0,564  0,012  Antifungal
0,580  0,034  Transcription factor NF kappa B inhibitor
0,519  0,006  Prostatic (benign) hyperplasia treatment
0,518  0,007  Antiulcerative
0,511  0,004  Antiviral (Influenza A)
0,529  0,025  Respiratory analeptic
0,506  0,021  CTGF expression inhibitor
0,493  0,022  Antineoplastic (pancreatic cancer)
0,475  0,006  Antiacne
0,472  0,006  Prostate disorders treatment
0,482  0,019  Antineoplastic (non-small cell lung cancer)
0,488  0,044  Antibacterial
0,482  0,044  CYP3A4 substrate
0,440  0,016  Antihypoxic
0,447  0,025  Mutagenic
0,443  0,021  UGT2B4 substrate
0,465  0,044  CYP2C9 substrate
0,429  0,008  Antiviral (Influenza)
0,431  0,011  Contraceptive
0,473  0,054  TNF expression inhibitor
0,444  0,029  NOS3 expression inhibitor
0,442  0,035  Antihypercholesterolemic
0,435  0,034  Caspase 3 stimulant
0,394  0,003  Alcohol dehydrogenase substrate
0,413  0,024  Antineoplastic (lymphoma)
0,397  0,011  Interferon gamma antagonist
0,412  0,027  Chemopreventive
0,418  0,034  Analeptic
0,443  0,066  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,394  0,020  Antineoplastic (lymphocytic leukemia)
0,390  0,022  Antineoplastic (endocrine cancer)
0,398  0,030  Cardiovascular analeptic
0,404  0,038  ICAM1 expression inhibitor
0,367  0,002  Aldehyde dehydrogenase substrate
0,398  0,036  Cytotoxic
0,384  0,022  Sodium/bile acid cotransporter inhibitor
0,378  0,020  Abortion inducer
0,370  0,015  UGT2B7 substrate
0,370  0,016  Hepatoprotectant
0,385  0,033  Antiprotozoal (Leishmania)
0,391  0,046  Hepatic disorders treatment
0,380  0,039  Antioxidant
0,373  0,041  Antineoplastic (cervical cancer)
0,377  0,045  Apoptosis antagonist
0,369  0,049  AR expression inhibitor
0,330  0,012  Neurotrophic factor enhancer
0,370  0,055  FMO1 substrate
0,357  0,050  Teratogen
0,341  0,036  Vascular (periferal) disease treatment
0,294  0,006  Contraceptive female
0,350  0,066  Bone diseases treatment
0,321  0,050  DNA damaging
0,299  0,032  Growth hormone agonist
0,279  0,013  Antifungal enhancer
0,287  0,022  Hair growth stimulant
0,281  0,016  Phospholipase A2 inhibitor
0,315  0,056  Embryotoxic
0,283  0,034  UGT1A4 substrate
0,278  0,030  Antialcoholic
0,267  0,023  UGT2B15 substrate
0,260  0,018  UGT2B9 substrate
0,303  0,065  Antiosteoporotic
0,286  0,048  Carcinogenic
0,247  0,012  Farnesoid X receptor antagonist
0,252  0,017  Cholesterol synthesis inhibitor
0,303  0,069  Cardioprotectant
0,278  0,051  UGT1A6 substrate
0,224  0,005  CDC25A inhibitor
0,305  0,087  Calcium channel activator
0,236  0,018  UGT2B10 substrate
0,223  0,007  Actinic keratosis treatment
0,245  0,032  Protein-tyrosine phosphatase inhibitor
0,271  0,067  Antipyretic
0,214  0,012  Androgen antagonist
0,224  0,023  Protein-tyrosine phosphatase 1B inhibitor
0,251  0,050  Anesthetic general
0,272  0,072  UGT1A9 substrate
0,237  0,041  Dual specificity phosphatase inhibitor
0,227  0,033  Protein kinase stimulant
0,291  0,097  Cholesterol antagonist
0,225  0,031  Phospholipase C inhibitor
0,230  0,037  Antiviral (Herpes)
0,197  0,005  TRPA1 antagonist
0,258  0,070  NOS2 expression inhibitor
0,238  0,052  UGT1A1 substrate
0,228  0,044  Antipruritic, non-allergic
0,226  0,042  Lipocortins synthesis antagonist
0,275  0,094  CYP2D6 substrate
0,212  0,033  Skin irritative effect
0,184  0,005  5-Alpha-reductase inhibitor
0,257  0,080  Aldehyde oxidase inhibitor
0,223  0,050  Dual specificity phosphatase 3 inhibitor
0,228  0,057  UDP-glucuronosyltransferase substrate
0,261  0,091  CYP1A2 substrate
0,174  0,008  Anabolic
0,188  0,023  Endometrios treatment
0,187  0,023  Antineoplastic antibiotic
0,202  0,040  Melanin inhibitor
0,197  0,036  Arachidonic acid antagonist
0,226  0,068  Antiparkinsonian, rigidity relieving
0,283  0,126  Immunosuppressant
0,165  0,010  UGT2B11 substrate
0,285  0,131  Antipruritic, allergic
0,214  0,061  Antihelmintic
0,166  0,014  ABCA1 expression enhancer
0,157  0,005  Na+ K+ transporting ATPase inhibitor
0,193  0,042  Anesthetic
0,253  0,103  Antipsoriatic
0,236  0,087  Proliferative diseases treatment
0,240  0,093  Chemoprotective
0,176  0,029  Adenylate cyclase stimulant
0,160  0,014  Contraceptive male
0,220  0,075  Antiparasitic
0,216  0,073  Antineoplastic enhancer
0,173  0,036  Aldehyde dehydrogenase inhibitor
0,233  0,098  5 Hydroxytryptamine release stimulant
0,209  0,075  Psychostimulant
0,137  0,003  Heme oxygenase stimulant
0,233  0,103  Immunostimulant
0,146  0,017  Transcription factor NF kappa B stimulant
0,136  0,016  Ornithine decarboxylase inhibitor
0,163  0,049  Neurotrophic factor
0,156  0,044  Retinoprotector
0,153  0,047  DNA polymerase I inhibitor
0,106  0,009  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,144  0,049  Adenylate cyclase inhibitor
0,187  0,093  Antihypertriglyceridemic
0,145  0,052  Antihyperlipoproteinemic
0,134  0,042  Choleretic
0,110  0,019  Aromatase inhibitor
0,097  0,007  Postcoital contraceptive
0,140  0,054  Topoisomerase II inhibitor
0,213  0,129  5 Hydroxytryptamine uptake stimulant
0,109  0,026  3C-Like protease (SARS coronavirus) inhibitor
0,103  0,019  Glycine receptor agonist
0,132  0,049  Microtubule formation inhibitor
0,205  0,123  Flavin-containing monooxygenase substrate
0,131  0,052  Menstruation disorders treatment
0,168  0,088  Antirickettsial
0,114  0,035  Paget's disease treatment
0,109  0,032  Bile acid receptor antagonist
0,138  0,063  Skin whitener
0,079  0,006  5-Alpha-reductase 2 inhibitor
0,118  0,046  Antiviral (SARS coronavirus)
0,118  0,046  Antiviral (Coronavirus)
0,078  0,007  Pregnane X receptor antagonist
0,113  0,043  Nitric-oxide synthase inhibitor
0,088  0,022  CDC25B inhibitor
0,171  0,106  Insulin sensitizer
0,071  0,009  RNA-directed RNA polymerase stimulant
0,074  0,013  Anesthetic inhalation
0,097  0,035  Glycine receptor antagonist
0,073  0,013  Aldosterone antagonist
0,114  0,055  Expectorant
0,193  0,134  DNA synthesis inhibitor
0,095  0,037  Antibiotic
0,180  0,122  Cytostatic
0,064  0,006  5-Alpha-reductase 1 inhibitor
0,080  0,023  Antimycoplasmal
0,117  0,061  Estrogen antagonist
0,129  0,075  CC chemokine 6 receptor antagonist
0,072  0,019  Lipocortins synthesis agonist
0,105  0,055  Estrogen receptor beta antagonist
0,055  0,007  Estrone sulfatase inhibitor
0,194  0,147  Transcription factor STAT inhibitor
0,085  0,038  Lipase inhibitor
0,096  0,050  Glutamate release inhibitor
0,103  0,058  Anticataract
0,057  0,013  Parathyroid hormone antagonist
0,052  0,008  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,060  0,017  Cholesterol esterase inhibitor
0,148  0,105  3C-like protease (Human coronavirus) inhibitor
0,096  0,055  SULT1E1 substrate
0,051  0,011  Glucose-6-phosphate dehydrogenase inhibitor
0,132  0,093  Pregnane X receptor agonist
0,067  0,027  Estrogen agonist
0,124  0,089  Lipid peroxidase inhibitor
0,072  0,039  SULT2A1 substrate
0,112  0,080  Antiviral (Hepatitis B)
0,208  0,177  GST M1-1 substrate
0,054  0,022  Nicotinic receptor alpha3 subunit antagonist
0,079  0,051  Estrogen receptor alpha antagonist
0,046  0,018  Retinoic acid alpha receptor agonist
0,043  0,017  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,045  0,020  GABA uptake inhibitor
0,045  0,020  Estrogen receptor beta agonist
0,033  0,009  Retinoid X gamma receptor agonist
0,050  0,027  Adenylate cyclase 1 inhibitor
0,126  0,106  UGT1A3 substrate
0,097  0,077  Antiinfertility, female
0,066  0,046  Hypercalcemia treatment
0,133  0,114  Movement disorders treatment
0,027  0,008  Progesterone agonist
0,031  0,012  Retinoid X gamma receptor antagonist
0,037  0,019  Tubulin agonist
0,117  0,099  Acaricide
0,066  0,048  Purinergic P2X2 antagonist
0,027  0,009  Vitamin D receptor antagonist
0,026  0,009  Retinoic acid gamma receptor agonist
0,039  0,023  Progesterone antagonist
0,048  0,032  Potassium channel Kv1.3 blocker
0,056  0,040  Acetyl-CoA transferase 2 inhibitor
0,059  0,043  Androgen agonist
0,113  0,098  Antineoplastic (squamous cell carcinoma)
0,076  0,061  Xanthine oxidase substrate
0,034  0,020  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,073  0,059  Keratolytic
0,073  0,060  Narcotic antagonist
0,113  0,100  Antihemorrhagic
0,041  0,028  Phenylethanolamine N methyltransferase inhibitor
0,046  0,033  Microtubule stabilization
0,017  0,004  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,090  0,077  Sulfotransferase substrate
0,050  0,038  Glucose-6-phosphate translocase inhibitor
0,023  0,012  Retinoid X beta receptor agonist
0,108  0,097  Antismoking
0,028  0,018  Hedgehog signaling activator
0,109  0,100  Antimutagenic
0,017  0,009  NMDA receptor phencyclidine site antagonist
0,077  0,069  Antineoplastic alkaloid
0,022  0,014  Corticosteroid-like
0,032  0,025  Estrogen receptor alpha agonist
0,023  0,016  CYP24 inhibitor
0,069  0,063  GABA aminotransferase inhibitor
0,064  0,059  Anticholelithogenic
0,022  0,018  Retinoic acid receptor agonist
0,019  0,016  Retinoic acid beta receptor agonist
0,006  0,004  Transcortin receptor antagonist
0,039  0,038  Geranyltranstransferase inhibitor
0,048  0,047  Postmenopausal disorders treatment
0,040  0,039  Alpha 1L adrenoreceptor agonist
0,144  0,144  Hypolipemic

